Search
My Cart

Borrelidin

SKU
B-1260
  • CAS:7184-60-3
  • Formula:C28H43NO6
  • MW:489.6
  • Appearance:White to off white-beige crystalline powder
  • Purity:>98%

Starting at $234.78

Product Name Qty
Borrelidin
1 mg
$234.78
Add to Compare Email
Loading...

Borrelidin is derived from Streptomyces rochei. It is 18-membered macrolide-polyketide and it is a compound with anti-viral, anti-bacterial, anti-malarial, and anti-angiogenic properties. It is a known inhibitor of bacterial and eukaryal threonyl-tRNA synthetases.

Borrelidin induces apoptosis in endothelial cells via the caspase 3 and caspase 8 pathway. In addition, borrelidin strongly inhibits capillary tube formation and also disrupts formed capillary tubes by inducing apoptosis of the tube-forming cells in a rat aorta matrix culture model.

In S.cerevisiae, borrelidin inhibits the cyclin-dependent kinase Cdc28/Cln2 with an ICof 24M, causing the arrest of both haploid and diploid cells in G phase and inducing the transcription of amino acid biosynthetic enzymes through a GCN4-dependent pathway. Borrelidin plays a role of antibiotic ligand in nascent peptide-dependent ribosome stalling.

 

 

 

More Information
Alternate Name/Synonyms
Cyclopentanecarboxylic acid, NSC 216128, Treponemycin
SKU
B-1260
CAS #
7184-60-3
Chemical Name
2-(7-Cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxooxacyclooctadeca-4,6-dien-2-yl)-cyclopentanecarboxylic acid
Chemical Formula
C28H43NO6
Molecular Weight
489.6
Appearance
White to off white-beige crystalline powder
Purity
>98%
Solubility
May be dissolved in DMSO or Ethanol
Storage Temp
Store desiccated at -20°C
THERAPEUTIC AREA
Oncological Disorders
USE
Borrelidin, a small molecule nitrile-containing macrolide inhibitor of threonyl-tRNA synthetase, is a potent inducer of apoptosis in acute lymphoblastic leukemia.
MDL NUMBER
MFCD08276914
CHEMACX
X1533650-2
INCHI
InChI=1S/C28H43NO6/c1-17-12-18(2)14-20(4)27(32)21(16-29)8-5-6-11-25(22-9-7-10-23(22)28(33)34)35-26(31)15-24(30)19(3)13-17/h5-6,8,17-20,22-25,27,30,32H,7,9-15H2,1-4H3,(H,33,34)/b6-5+,21-8-/t17-,18+,19-,20-,22+,23+,24-,25-,27+/m0/s1
SMILES
C[C@H]1C[C@H](C[C@@H]([C@H](/C(=CC=CC[C@H](OC(=O)C[C@@H]([C@H](C1)C)O)[C@@H]2CCC[C@H]2C(=O)O)/C#N)O)C)C
Peptide sequence
Not Applicable
RTECS
ED8750000
UN #'S
Not Applicable
PACKING GROUP
Not Applicable
HAZARD CLASS
Not Applicable
Handling
Protect from light
Citations
Role of antibiotic ligand in nascent peptide-dependent ribosome stalling Nora Vzquez-Laslop, Dorota Klepacki, Debbie C. Mulhearn, Haripriya Ramu, Olga Krasnykh, Scott Franzblau, and Alexander S. Mankin PNAS, Jun 2011; 108: 10496 - 10501.
Citations_Hyperlink
http://www.pnas.org/cgi/reprint/108/26/10496
Certificate of Analysis 1
B-1260, G1128.pdf
Certificate of Analysis 2
B-1260, E1098B.pdf
Certificate of Analysis 3
B-1260, F1149B.pdf
HandlingProtect from light
UN #'SNot Applicable
Packing GroupNot Applicable
CitationsRole of antibiotic ligand in nascent peptide-dependent ribosome stalling
Related Products
We found other products you might like!
To Top